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DFF45 is a subunit of the DNA fragmentation factor
(DFF) that is cleaved by caspase-3 during apoptosis.
However, the mechanism by which DFF45 regulates
apoptotic cell death remains poorly understood. Here
we report the identification and characterization of
two mammalian genes, CIDE-A and CIDE-B, encoding
highly related proteins with homology to the N-terminal
region of DFF45. CIDE-A and CIDE-B were found to
activate apoptosis in mammalian cells, which was
inhibited by DFF45 but not by caspase inhibitors.
Expression of CIDE-A induced DNA fragmentation in
293T cells, which was inhibited by DFF45, further
suggesting that DFF45 inhibits the apoptotic activities
of CIDEs. In addition to mammalian CIDE-A and
CIDE-B, we identified DREP-1, a Drosophila melano-
gaster homolog of DFF45 that could inhibit CIDE-A-
mediated apoptosis. Mutant analysis revealed that
the C-terminal region of CIDE-A was necessary and
sufficient for killing whereas the region with homology
to DFF45 located in the N-terminus was required for
DFF45 to inhibit CIDE-A-induced apoptosis. CD95/
Fas-mediated apoptosis was enhanced by CIDEs but
inhibited by DFF45. These studies suggest that DFF45
is evolutionarily conserved and implicate CIDEs as





Apoptosis, a morphologically defined form of programmed
cell death (PCD) plays an essential role in animal develop-
ment and tissue homeostasis (Jacobson et al., 1997). The
apoptotic mechanism is controlled by an evolutionarily
conserved genetic program which is activated in the dying
cell (Thompson, 1995; White, 1996; Jacobson et al.,
1997). Several regulatory components of the apoptotic
pathway have been identified in various living organisms
including man (Thompson, 1995; White, 1996). In the
nematode Caenorhabditis elegans, three genes, ced-3, ced-
4 and ced-9, play critical roles in the regulation of the
death pathway. CED-9, the nematode homolog of Bcl-2
and Bcl-XL, binds to CED-4 and represses cell death by
interacting with and inhibiting the activity of the cysteine
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protease CED-3 through CED-4 (Chinnaiyan et al., 1997;
Spector et al., 1997; Wu et al., 1997a,b).
A family of cysteine proteases (designated caspases)
related to the C.elegans CED-3 protein has been identified
in mammalian cells (Alnemri et al., 1996; Cohen, 1997).
Caspase activation is induced by a wide array of death
signals and leads to cleavage of target proteins and
execution of the apoptotic program (Cohen, 1997). Repres-
sion of caspase enzymatic activity by viral proteins, p35
from baculovirus and CrmA from cowpox virus, as well
as by synthetic peptides inhibits apoptosis induced by
stimulation of members of the tumor necrosis factor (TNF)
family of cell surface death receptors including CD95/
Fas/Apo-1, TNF-R1 and DR3/TRAMP (Nagata, 1997).
These observations suggest that the execution phase of
the apoptotic process induced by cell death receptors
requires caspase activity. However, in other systems of
apoptosis, cell death can proceed in spite of caspase
inhibition, suggesting the existence of caspase-dependent
and caspase-independent mechanisms that are sufficient
for cell death (Xiang et al., 1996; McCarthy et al., 1997).
The downstream events that follow caspase activation
are poorly understood. Several intracellular substrates
including poly(ADP-ribose) polymerase (Lazebnik et al.,
1994; Nicholson et al., 1995), sterol-regulatory element-
binding proteins (SREBPs) (Wang et al., 1995), the U1-
associated 70 kDa protein (Casciola-Rosen et al., 1995),
the DNA-dependent protein kinase (Casciola-Rosen et al.,
1996; Song et al., 1996) and the retinoblastoma B protein
(RB) (An and Dou, 1996) are cleaved by activated
caspases. However, it is unclear whether the cleavage of
any of these proteins plays a pivotal role in the induction
of apoptosis.
A heterodimeric protein, designated DNA fragmentation
factor (DFF), that mediates DNA fragmentation of isolated
nuclei has been purified through cellular fractionation
experiments (Liu et al., 1997). DFF is composed of 45
and 40 kDa subunits, of which only the cDNA encoding
the 45 kDa subunit has been cloned (Liu et al, 1997).
DFF45, but not DFF40, is cleaved by active caspase-3
into three proteolytic fragments, a step that appears to be
required for DFF to mediate DNA fragmentation in vitro
(Liu et al., 1997). However, the effector moiety of DFF
that is activated by caspase-3 remains poorly understood.
Furthermore, it is unclear whether DFF is necessary for
induction of DNA fragmentation and apoptosis in vivo.
DFF is devoid of nuclease activity when incubated with
naked DNA, suggesting that DFF mediates DNA frag-
mentation by an indirect mechanism perhaps as a com-
ponent of a signaling cascade that ultimately leads to
DNA fragmentation. In order to begin to understand the
role of DFF in apoptosis, we searched public databases
for novel proteins with homology to DFF45. In the current
study, we report the identification and characterization of
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Fig. 1. Primary structure and alignments of mouse CIDE-A, CIDE-B and FSP27, human CIDE-A and D.melanogaster DREP-1. (A) Schematic
structure of CIDE-A, CIDE-B, DREP-1 and DFF-45. CIDE-N, CIDE-C and DFF-C domains are shown as closed, light gray and dark gray boxes
boxes, respectively. The region specific for CIDE-A* is shown as a hatched box. (B) Amino acid sequence and alignments of N-terminal regions of
CIDEs, FSP27 (mouse), DREP-1 and DFF45. (C) Amino acid sequence and alignments of C-terminal regions of CIDEs and FSP27 (mouse).
(D) Amino acid sequence and alignments of C-terminal regions of DREP-1 and DFF45. Proposed conserved blocks are overlined. The putative
alternative initial codon of mCIDE-A is indicated by a star. Each entire sequence of mouse CIDE-A, CIDE-B, FSP27, human CIDE-A, DFF45 and
D.melanogaster DREP-1 is shown in (C) and (D). The nucleotide sequences which encode mouse CIDE-A, CIDE-B and FSP27, human CIDE-A,
DFF45 and DREP-1 are available as AF041376, AF041377, M61737, AF041378, U91985 and AF041375, respectively, in GenBank.
two mammalian genes (CIDE-A and CIDE-B) and a
Drosophila gene (DREP-1), that encode proteins with
significant homology to DFF45.
Results
Identification of mammalian CIDEs and Drosophila
DREP-1
To identify potential DFF45-related genes, we searched
the expressed sequence tag (EST) database of GenBank
for clones with homology to DFF45 (Liu et al., 1997).
Two types of mouse ESTs encoding two distinct peptides
with statistically significant amino acid homology to
DFF45 were identified (P 210–3) by the TBLASTN
program. Subsequent sequence analysis revealed that the
ESTs represented two different genes with open reading
frames encoding highly homologous proteins of 200 and
219 amino acids (Figure 1). We designated these mouse
genes CIDE-A and CIDE-B (for cell death-inducing
DFF45-like effector A and B). In addition, a human EST
clone with 83% amino acid identity with mouse CIDE-A
was identified and it appears, therefore, to represent the
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human homolog of CIDE-A (Figure 1). Analysis of the
nucleotide sequence of both human and mouse CIDE-A
cDNAs revealed two potential in-frame translation initi-
ation sites separated by 51 nucleotides. These two potential
initiation codons produce a protein of 217 amino acids
(designated CIDE-A*) and a protein identical to CIDE-A*
but lacking its 17 most N-terminal amino acids (designated
CIDE-A). BLAST search revealed that CIDE-A and -B
were novel molecules highly homologous to FSP27 (Figure
1B), a protein of unknown function whose expression is
associated with terminal differentiation of fat cells
(Danesch et al., 1992). The homology of CIDE-A, CIDE-B
and FSP27 with DFF45 was restricted to an N-terminal
region designated here as CIDE-N domain which showed
39, 29 and 38% amino acid identity respectively with
DFF45. Another region of CIDE-A and CIDE-B, termed
CIDE-C domain, located in their C-termini shared amino
acid homology (54 and 53% identity, respectively) with
FSP27 but not with DFF45 (Figure 1). To determine if
DFF45-related molecules are conserved in other species,
we searched the invertebrate EST database of GenBank
for clones with homology to DFF45. We identified a
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Fig. 2. Tissue distribution of the CIDE-A and CIDE-B transcripts. Expression of CIDE-A (A) and CIDE-B (B) in human tissues was analyzed by
Northern blot analysis. PBL, peripheral blood leukocytes. X-ray films were exposed for 16 h.
Drosophila melanogaster gene encoding a peptide with
significant homology to DFF45, designated here as
DREP-1. The similarity between DREP-1 and DFF45,
CIDE-A and CIDE-B was most significant at the
N-termini. Significantly, the C-terminus of DREP-1 has
homology to that of DFF45 but not to that of CIDE-A,
CIDE-B and FSP27 (Figure 1B and D). Importantly, two
aspartic acid residues known to be part of a caspase-3
recognition site in DFF45 (Liu et al., 1997) were also
conserved in Drosophila DREP-1 (Figure 1D).
Differential expression of CIDE-A and -B mRNA in
human tissues
We performed Northern blot analysis to determine the
distribution of CIDE-A and CIDE-B RNA transcripts in
various human tissues. Expression of CIDE-A was detected
in heart and at a lower level in skeletal muscle, brain,
lymph node, thymus, appendix and bone marrow as a
1.3 kb transcript. A smaller transcript of 1.0 kb was
expressed at low levels in the placenta. In addition, another
transcript of ~7.0 kb was detected with the CIDE-A probe
in kidney and at a lower level in heart, brain, placenta
and lung (Figure 2A). The expression pattern of CIDE-B
was different from that of CIDE-A. Hybridization with a
CIDE-B probe revealed a major transcript of 1.3 kb in
adult and fetal liver (Figure 2B). In addition, another
transcript of ~2.5 kb was detected at lower levels in
spleen, peripheral blood lymphocytes, bone marrow and
fetal liver (Figure 2B). CIDE-A but not CIDE-B mRNA
was expressed in 293T embryonic kidney, MCF-7 breast
carcinoma and SHEP neuroblastoma cells (data not
shown).
CIDE-A and -B but not DFF45 activate apoptotic
cell death
To begin to elucidate the physiological function of CIDE
proteins, expression constructs producing CIDE-A,
CIDE-B and DFF45 were introduced into 293T cells and
subsequently observed for features of apoptosis. The
CIDE-A-, but not DFF45-transfected cells, displayed
morphological features of adherent cells undergoing apop-
tosis, such as becoming rounded with plasma membrane
blebbing, condensed nuclei and detachment from the dish
(data not shown). In addition, CIDE-A, but not DFF45,
induced nuclear condensation and fragmentation, a feature
2528
characteristic of apoptosis (Figure 3A). Expression of both
CIDE-A and CIDE-A*, the products of the two potential
initiation codons, induced significant killing of 293T cells
in a dose-dependent manner as did CIDE-B (Figure 3B).
In contrast, expression of DFF45 or the related protein
DREP-1 did not induce apoptosis (Figure 3B). In addition
to 293T cells, expression of CIDE-A induced significant
apoptotic cell death in MCF-7 cells as compared with
control plasmid (Figure 3C, P 0.001). In addition,
CIDE-A and CIDE-B induced apoptosis in SHEP cells
(data not shown). We confirmed these results in cells
transfected with plasmids expressing untagged CIDE-A*,
CIDE-A, CIDE-B, DREP-1 and DFF45, indicating that
the untagged and Flag-tagged proteins exhibit the same
activities when transfected in cells (data not shown).
Western blot analysis revealed that CIDE-A, CIDE-A*,
CIDE-B, DREP-1 and DFF45 were expressed in cells,
indicating that the lack of expression did not account for
the inability of DFF45 to induce apoptosis (data not
shown, and Figure 7). These results indicate that CIDE-
A and CIDE-B proteins, but not DFF45, induce apoptosis
in mammalian cells. Thus, CIDE-A and CIDE-B exhibit
a non-overlapping pattern of expression in human tissues.
CIDE-A and -B-induced apoptosis is inhibited by
DFF45 and Drosophila DREP-1
To determine if DFF45 modulates the ability of CIDEs to
induce cell death, these proteins were co-expressed in
293T cells and the level of apoptosis was measured.
Expression of DFF45 significantly inhibited the killing
activity of CIDE-A and CIDE-B (Figure 4A, P 0.001).
Furthermore, the Drosophila DREP-1 protein also sup-
pressed the ability of CIDE-A to induce apoptosis, further
suggesting that DREP-1 is a homolog of DFF45 (Figure
4A, P 0.001).
Expression of CIDE-A induces oligonucleosomal
DNA fragmentation that is inhibited by DFF45 in
293T cells
Activation of DFF induces DNA fragmentation of isolated
nuclei in vitro (Liu et al., 1997). Therefore, we tested
next whether expression of CIDE-A or DFF45 could
induce DNA fragmentation in 293T cells. Consistent with
the results presented in Figure 4A, CIDE-A and caspase-8
(positive control) promoted the fragmentation of genomic
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Fig. 3. CIDEs induce apoptosis in mammalian cells. (A) Ectopic expression of CIDE-A induces apoptosis of 293T cells. 293T cells (3105) were
co-transfected with 2 μg of pcDNA3 (a), pcDNA3-Flag-CIDE-A (b) or pcDNA3-Flag-DFF45 (c). Nuclei of transfected cells were stained at 18 h
after transfection as described (Inohara et al., 1997b). Magnification 400. (B) Apoptosis of 293T cells was induced by CIDE-A and CIDE-B but
not by DFF45 and DREP-1. 293T cells (3105) were co-transfected with the indicated amount of expression plasmid of Flag-tagged CIDE-A,
CIDE-A*, CIDE-B, DFF-45 or DREP-1 together with a β-galactosidase-expressing reporter construct. The data (mean  SD) represent the
percentage of round, apoptotic cells with membrane blebbing as a function of total β-galactosidase-positive cells (n  3). (C) Ectopic expression of
CIDE-A induces apoptosis in MCF7 cells. MCF7 cells (1105 ) were co-transfected with pcDNA3 or pcDNA3-Flag-CIDE-A and a β-galactosidase-
expressing reporter construct. The percentage of apoptotic cells was determined as in (B).
Fig. 4. DFF-45/DREP-1 can inhibit apoptosis induced by CIDEs. (A) DFF45 can block apoptosis induced by CIDE-A and CIDE-B. 293T cells
(3105) were co-transfected with pcDNA3 vector alone, 2 μg of pcDNA3-Flag-CIDE-A, 0.5 μg of pcDNA3-Flag-CIDE-A* or 2 μg of pcDNA3-
Flag-CIDE-B plus pcDNA3 or 3 μg plus pcDNA3 or pcDNA3-Flag-DFF45. The total amount of DNA was always 5 μg, adjusted with pcDNA3.
The percentage of apoptotic cells was determined as in Figure 3. (B) DFF45 can inhibit DNA fragmentation induced by CIDE-A*. 293T cells
(3105 ) were co-transfected with pcDNA3 vector alone or with 1 μg of pcDNA3-Flag-CIDE-A*, 3 μg of pcDNA3-Flag-DFF45, 1 μg of pcDNA3-
Flag-CIDE-A* plus 3 μg of pcDNA3-Flag-DFF45 or 1 μg of pcDNA3-caspase-8-AU1. The total amount of DNA for transfection was always 5 μg,
adjusted with pcDNA3. The genomic DNA was extracted from cells and aliquots of one-tenth were loaded into agarose gel.
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Fig. 5. Caspase inhibitors cannot block CIDE-A-induced apoptosis.
293T cells (3105 ) were co-transfected with pcDNA3 vector alone,
2 μg of pcDNA3, 2 μg of pcDNA3-Flag-CIDE-A, 2 μg of pcDNA3-
Flag-CIDE-A plus 2 μg of pcDNA3-crmA or 1 μg of pcDNA3-
caspase-8-AU1. At 8 h after transfection, 20 μM of the caspase
inhibitor, zVAD-fmk or zDEVD-fmk, or a control peptide, zFA-fmk
dissolved in dimethylsulfoxide (DMSO) was added. No cell death was
observed 8 h after transfection. Cell death assays were performed as in
Figure 3B.
DNA into oligonucleosomal fragments (Figure 4B). More-
over, DNA fragmentation induced by CIDE-A was
inhibited by DFF45 (Figure 4B).
Apoptosis induced by CIDE-A is unaffected by
caspase inhibitors zVAD-fmk, zDEVD-fmk or the
cowpox protein CrmA
We next determined whether apoptosis activated by
CIDE-A expression is caspase dependent. In these experi-
ments, 293T cells were transfected with constructs produc-
ing CIDE-A in the presence or absence of caspase
inhibitors and the level of apoptosis in the cells was
evaluated. The killing activity of CIDE-A was unaffected
by the broad-spectrum caspase peptide inhibitors zVAD-
fmk and zDEVD-fmk or CrmA, a product of the cowpox
virus that inhibits caspases (Figure 5). In control experi-
ments, apoptosis induced by caspase-8 was inhibited by
the same concentration of zVAD-fmk (Figure 5).
Apoptosis mediated by CD95/Fas is partially
inhibited by DFF45
An important pathway that transmits signals leading to
cell death in mammals is that activated through the CD95/
Fas receptor (Nagata, 1997). We next tested whether
CIDE-A and DFF45 could modulate apoptosis induced
by CD95/Fas signaling. Figure 6 shows that expression
of CIDE-A enhanced the apoptotic activities induced by
Fas signaling and CLARP, a caspase-like protein (also
called CASPER/cFlipL/I-FLICE/FLAME-1/CASH) that
interacts with caspase-8, a component of the CD95/Fas
pathway (Inohara et al., 1997a). In contrast, DFF45
inhibited apoptosis induced by Fas and CLARP (Figure 6).
The C-terminal region of CIDE-A is necessary and
sufficient for killing whereas its N-terminus is
required for DFF45 to inhibit CIDE-A-induced
apoptosis
We engineered two mutant forms of CIDE-A to character-
ize further the ability of CIDE-A to induce apoptosis.
Mutant CIDE-A (1–107) contains the N-terminal half of
2530
Fig. 6. Fas-, CLARP-induced apoptosis is enhanced by CIDE-A and
blocked by DFF45. 293T cells (3105 ) were co-transfected with 2 μg
of CIDE-A or DFF-45 expression plasmids plus 0.7 μg of pcDNA3-
Fas or 1 μg of pcDNA3-CLARP-HA. Cell death assays were
performed as in Figure 3B.
the protein with homology to DFF45, whereas mutant
CIDE-A (108–200) contains the C-terminal half (Figure
7A). CIDE-A (108–200) was capable of inducing
apoptosis, whereas the CIDE-A (1–107) mutant did not
(Figure 7B), indicating that the killing activity of CIDE-A
resides in its C-terminal half. While apoptosis induced by
wild-type CIDE-A was inhibited by DFF45 (Figure 4A
and B), apoptosis of the CIDE-A (108–199) mutant was
not inhibited by DFF45 (Figure 7B), implying that the
N-terminal region was required for the inhibition by
DFF45. Significantly, the killing activity of the CIDE-A
mutant (108–200) was greater than that elicited by wild-
type CIDE-A (Figure 7B), suggesting that the CIDE-A
activity could be regulated negatively by endogenous
proteins such as DFF45 through its N-terminal region
(residues 1–107). Consistent with the latter, expression of
the mutant CIDE-A (1–107) protein antagonized the
inhibition of CIDE-A-induced apoptosis by DFF45 (Figure
7B). Immunoblot analysis revealed that wild-type CIDE-A
and mutant CIDE-A (1–107) proteins were expressed at
comparable levels whereas the expression of the CIDE-A
(108–200) mutant that exhibited killing activity was
detected at lower levels (Figure 7C, lower panel), perhaps
due to the high level of apoptosis induced by the latter
mutant form of CIDE-A (Figure 7B). These results indicate
that the C-terminus of CIDE-A is necessary and sufficient
for killing while the N-terminal region with homology to
DFF45 is required for DFF45 to inhibit CIDE-A-mediated
apoptosis.
Discussion
We describe here CIDE-A and CIDE-B, two members of
a family of proteins that activate apoptosis in mammalian
cells. Another member of the family is FSP27, a protein
associated with terminal differentiation of fat cells
(Danesch et al., 1997). The expression of FSP27 is
regulated by the tumor necrosis pathway, but it is not
known if FSP27 is involved in the regulation of cell death
(Williams et al., 1992). CIDEs and FSP27 contain an
N-terminal region with homology to DFF45, a subunit of
DFF (Liu et al., 1997).
CIDE-A and CIDE-B activate apoptosis and appear to
CIDE, a novel family of apoptosis activators
Fig. 7. Mutation analysis of CIDE-A. (A) Scheme of CIDE-A mutants. (B) The CIDE-C domain induced apoptosis but not CIDE-N, which is
required for inhibition of CIDE-A-induced apoptosis by DFF-45. A total of 3105 293T cells were co-transfected with 2 μg of pcDNA3-Flag-
CIDE-A, pcDNA3-Flag-CIDE-A (1–107), pcDNA3-Flag-CIDE-A (108–200), pcDNA3-Flag-DFF45 or vector control. At 24 h after transfection,
Flag-tagged proteins were detected with monoclonal anti-Flag antibody. Cell death assays were performed as in Figure 3B. (C) Expression of
CIDE-A, its mutants and DFF45. 293T cells were transfected as above and lysed with NP-40-containing buffer at 24 h after transfection. Tagged
proteins were detected with an ECL kit with X-ray film. Images exposed for 10 s and 30 min are shown in the upper and lower panels, respectively.
A total of 100 μg of protein was loaded in each lane.
function as positive effectors of the apoptotic pathway.
Recent studies have provided insight into the effector
mechanism that mediates DNA fragmentation and clues
as to how CIDEs could function in apoptosis. Two proteins,
CAD and ICAD, have been identified as downstream
regulators of DNA fragmentation (Enari et al., 1998;
Sakahira et al., 1998). ICAD exhibits high homology to
DFF45 and appears to represent its mouse ortholog (Enari
et al., 1998). ICAD interacts with and inhibits the activity
of CAD, a 40 kDa protein that exhibits DNase activity
and probably represents the mouse counterpart of DFF40
(Enari et al., 1998). Apoptotic stimuli that activate
caspase-3 can cleave ICAD/DFF45, leading to the release
and activation of CAD (Enari et al., 1998), a hypothesis
that is compatible with the finding that caspase-3 is
required for activation of DFF (Liu et al., 1997). CIDEs
could function as signaling components that regulate the
ability of CAD to mediate DNA fragmentation. In this
model, CIDEs act as upstream regulators of CAD or
alternatively they could be co-factors of CAD required
for DNase activity. In this regard, CAD has been shown
to exhibit DNase activity when expressed in mammalian
cells or in an in vitro reticulocyte system in the presence
of ICAD and caspase-3 (Enari et al., 1998). It is possible
that additional factors in the cell lysates may have con-
tributed to the DNase activity. The observation that DNA
fragmentation activity induced by CIDEs was not affected
by caspase inhibitors is consistent with a model in which
CIDEs and CAD act in concert downstream from caspases
to mediate DNA fragmentation. However, we cannot rule
out an alternative model in which CIDEs could be part of
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a DFF45-inhibitable pathway that leads to the activation
of a DNase activity distinct from CAD.
The C-terminal region of CIDEs appears to contain the
effector domain since this region was necessary and
sufficient for killing activity. The N-terminal region of
CIDEs, which is homologous to that of DFF45, could
regulate the killing activity of CIDEs perhaps through
homophilic interactions. These could involve association
of CIDEs with DFF45 or with other proteins containing
domains with homology to the N-terminal region of
DFF45. This hypothesis is supported by these observations.
First, the region of CIDEs with homology to DFF45 was
required for DFF45 to inhibit CIDE-mediated apoptosis.
Second, the killing activity of the CIDE-A mutant (108–
200) was greater than that of the wild-type protein,
suggesting that CIDE-A is regulated negatively through
its N-terminal region that has homology to DFF45. Finally,
a mutant form of CIDE-A (1–107) that contained the
region with homology to DFF45 antagonized the DFF45
inhibition of CIDE-A-induced apoptosis. However, we
have been unable to show that DFF45 and CIDEs interact
in mammalian cells (N.Inohara and G.Núñez, unpublished
observations), suggesting that proteins other than DFF45
could be involved in these interactions. A possible candid-
ate is CAD. Future experiments will determine whether
CIDEs interact with and regulate the activity of CAD.
We have observed that CIDEs induce DNA fragment-
ation as well as other morphological features of apoptosis,
including nuclear condensation and membrane blebbing.
Two possibilities can be envisioned to explain these
observations. First, DNA cleavage elicited by CIDEs could
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result in secondary activation of effectors responsible for
morphological features of apoptosis observed upon CIDE
expression. Alternatively, CIDEs could directly engage
cytosolic and/or nuclear targets in addition to those
responsible for DNA fragmentation.
We have identified DREP-1, a Drosophila protein related
to DFF45. DREP-1 protein may represent the fly homolog
of DFF45/ICAD. Three observations support this notion.
First, DFF45/ICAD and DREP-1 share significant amino
acid and structural homology. The similarity between
DREP-1 and DFF45/ICAD was most significant at the
N-termini, but also extended to their C-terminal regions.
Second, two aspartic acid residues known to be part of a
caspase-3 recognition site in DFF45/ICAD were also
conserved in DREP-1. These two aspartic residues in
DFF45/ICAD are cleaved during the activation of DFF
by caspase-3 (Liu et al., 1997) and are important for the
release of ICAD from CAD (Enari et al., 1998; Sakahira
et al., 1998). Finally, both DFF45 and DREP-1 can inhibit
apoptosis induced by CIDEs. However, these results only
suggest that DREP-1 is the Drosophila ortholog of DFF45/
ICAD, and additional experiments are required to establish
a role for DREP-1 in programmed cell death. The conserv-
ation of DFF45/ICAD in flies suggests an important role
for these proteins in both vertebrate and invertebrate
apoptosis.
Materials and methods
Isolation of the DFF45-related genes
cDNA clones of mouse CIDE-A, human CIDE-A, mouse CIDE-B and
DREP-1 were found in the GenBank EST database, using the TBLASTN
program. The EST clones 337992 (mCIDE-A), 351557 (mCIDE-A
and mCIDE-A*), 152917 (hCIDE-A), 551880, 790532 (mCIDE-B),
LD15946, LD16627 (DREP-1) and 525788 (hDFF45), which encode
whole proteins, were obtained from IMAGE Consortium, and their
nucleotide sequences were determined by dideoxy sequencing.
Northern blot analysis
The entire cDNA inserts of EST clones 337992 (mCIDE-A) and 790532
(mCIDE-B) were radiolabeled by random priming using a commercial
kit (Boehringer Mannheim) and applied for analysis of human poly(A)
RNA blots from various tissues (Clontech Laboratories) according to
the manufacturer’s instructions.
Construction of expression plasmids
The entire cDNA inserts of EST clones 337992 (mCIDE-A), 351557
(mCIDE-A*), 790532 (mCIDE-B), LD15946 (DREP-1) and 525788
(hDFF45) were cloned into the EcoRI and NotI sites of pcDNA3
(Invitrogen) to produce expression plasmids. To produce tagged proteins,
we constructed pcDNA3-Flag and pcDNA3-HA which are derivatives
of pcDNA3 (Invitrogen) and share common restriction enzyme sites for
cloning. The entire open reading frame of mCIDE-A, mCIDE-A*,
mCIDE-B, DREP-1 and hDFF45 were inserted into the XbaI and ApaI
sites of pcDNA3-Flag to produce N-terminal Flag-tagged proteins.
Deletion mutants CIDE-A (1–107) and CIDE-A (108–200) were con-
structed by a two-step PCR mutagenesis method as described (Inohara
et al., 1997b). pcDNA3-crmA and pcDNA3-caspase-8-AU1 were
described previously (Inohara et al., 1997a). The human CLARP was
cloned into the BamHI and XhoI sites of pcDNA3-HA to generate
C-terminal HA-tagged CLARP protein. The authenticity of all constructs
was confirmed by dideoxy sequencing and the expression of tagged
proteins was confirmed by Western blot using monoclonal antibodies to
Flag (Kodak) and HA (Boehringer Mannheim).
Transfection, expression and immunodetection of tagged
proteins
A total of 5106 human 293T cells (Numa et al., 1995) were transfected
with expression plasmids by a calcium phosphate method as described
(Inohara et al., 1997a). The total amount of transfected plasmid DNA
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was adjusted with pcDNA3 plasmid to be always the same within
individual experiments. After transfection, 293T cells were harvested at
24 h and lysed with 0.2% NP-40 isotonic lysis buffer (Inohara et al.,
1997b). Total lysates were subjected to 12% SDS–PAGE and immuno-
blotted with monoclonal antibodies to Flag (Kodak).
Apoptosis assays, fluorescence staining of nuclear DNA and
DNA fragmentation assay
A total of 5105 293T cells were co-transfected with 0.2 μg of pcDNA3-
β-gal plus each expression plasmid in triplicate by the calcium phosphate
method as reported (Inohara et al., 1997a). MCF7 were co-transfected
with vector control or CIDE-A and a β-galactosidase-expressing reporter
construct by Lipofectamine (Gibco-BRL) according to the manufacturer’s
instructions. In some experiments, 20 μM zVAD-fmk [benzyloxycar-
bonyl-Val-Ala-Asp-(OMe)-fluoromethylketone], zFA-fmk [benzyloxy-
carbonyl-Phe-Ala-(OMe)-fluoromethylketone] and zDEVD-fmk [benzyl-
oxycarbonyl-Asp-Glu-Val-Asp-(OMe)-fluoromethylketone] were added
to the medium at 8 h after transfection. zFA-fmk, zVAD-fmk and
zDEVD-fmk were obtained from Enzyme Systems. At 24 h after
transfection, cells were fixed, stained for β-galactosidase as described
(Inohara et al., 1997a) and assayed for morphological features of
apoptosis. At least 300 blue-staining cells were counted. Statistical
significance was determined by one-way ANOVA followed by Student–
Neuman–Keuls post-hoc comparisons.
Nuclear staining with acridine orange was performed as described
(Inohara et al., 1997b). Genomic DNA was extracted and analyzed for
DNA fragmentation as described (Liu et al., 1997).
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